🇺🇸 FDA

Company profile · Sponsor

Janssen-Cilag

Janssen-Cilag International NV

E14F52E · EMA pharma EU
Pipeline
1
Drugs
0
Patents
0

Quick answer

Janssen-Cilag (E14F52E) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E14F52E
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (1)

Search pipeline →

  1. Simponi 50 mg solution for injection in pre-filled syringe., Simponi 45 mg/0.45 mL solution for injection in pre-filled pen., Simponi 100 mg solution for injection in pre-filled syringe.

    Janssen-Cilag

    Ulcerative Colitis

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Janssen-Cilag?

Janssen-Cilag (E14F52E) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Janssen-Cilag sponsor?

We track 1 ClinicalTrials.gov-linked program for Janssen-Cilag, including Simponi 50 mg solution for injection in pre-filled syringe., Simponi 45 mg/0.45 mL solution for injection in pre-filled pen., Simponi 100 mg solution for injection in pre-filled syringe.. Open each program for phase, modality, NCT IDs, and indication details.

Where does Janssen-Cilag company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.